Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #409 on Acasti Pharma, Inc (ACST)
I.B.Broke
03/04/18 6:31 PM
#410 RE: caloosa #409
Acasti will immediately begin the process of recruiting new directors and expects to regain compliance with Nasdaq Listing Rule 5605 and National Instrument 52-110 of the Canadian securities regulators, which require a company’s audit committee to be comprised of at least three independent directors, within six months and in any event prior to Acasti’s next annual shareholders’ meeting.